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Abstract
Background The technical developments of imaging meth-
ods over the last 2 decades are changing our knowledge of
perinatal oncology. Fetal ultrasound is usually the first
imaging method used and thus constitutes the reference
prenatal study, but MRI seems to be an excellent comple-
mentary method for evaluating the fetus. The widespread
use of both techniques has increased the diagnosis rates of
congenital tumors. During pregnancy and after birth, an
accurate knowledge of the possibilities and limits of the
different imaging techniques available would improve the
information obtainable, thus helping the medical team to
make the most appropriate decisions about therapy and to
inform the family about the prognosis.
Conclusion In this review article, we describe the main
congenital neoplasms, their prognosis and their imaging
characteristics with the different pre- and postnatal imaging
methods available.
Keywords Pediatric oncology.Prenatal diagnosis.
Fetal US.Fetal MRI.Neonatal imaging
Introduction
Tumors are considered congenital when detected during
pregnancy or in the first 3 months of life [1, 2]. Congenital
tumors represent only 1.5–2% of all pediatric tumors, with
a prevalence of 1:12,500 to 1:27,500 live births [3–5].
Recent studies demonstrate an increase in the incidence of
congenital tumors [6], probably as a consequence of both
the generalization of routine prenatal and neonatal medical
controls and of the improvement of prenatal imaging
techniques.
Congenital tumors differ in many aspects from tumors
presenting in older children, with respect to histology,
behavior and prognosis. The most frequent congenital tumor
types are shown in Table 1 [2, 3, 5–8]. The diagnosis of a
congenital tumor involves a tremendous emotional impact
for a family and implies ethical questions about prognosis,
therapy possibilities and long-term consequences of the
treatment. Prognosis is related not only to the histological
type, but also to the size and location of the tumor and the
presence or not of associated congenital anomalies, which
are found in 15–20.8% of cases [5, 9]. Another prognostic
factor is the age at which the lesion is detected, with most
histological tumor types showing a worse prognosis for cases
detected during pregnancy [10–14].
Over the last few years, we have witnessed significant
technical improvements in prenatal imaging diagnostic
tools. Ultrasound is usually the first imaging method used,
but antenatal magnetic resonance imaging (MRI) is in-
creasingly being used as a complementary study. Standard
postnatal imaging methods include conventional X-ray,
ultrasound, CT and MRI.
The purposes of this review are to describe the most
frequent types of congenital tumors and their prognosis, to
review the main imaging characteristics of this heterogeneous
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and postnatal imaging methods in the characterisation of
congenital tumors, with special emphasis on prenatal MRI.
Extracranial teratomas
Extracranial teratomas are neoplasms derived from the
primordial germ cells. They may contain components
arising from all three germ layers and therefore may present
different tissue types. Most congenital teratomas are
histologically benign and typically located mid-line. The
main location of these tumors is the sacrococcygeal region
(45% of cases), followed by the cervicofacial area (28%)
and the thorax (11%) [11].
Sacrococcygeal teratomas (SCT) are one of the most
common overall congenital neoplasms, with an incidence of
1:40,000 infants and a female predominance of 4:1 [15,
16]. They arise from rests of pluripotent cells at the caudal
end of the notochord, originating from the coccyx. Of all
teratomas, these tumors are associated with the highest
incidence of malignancy (10%) and of associated anomalies
(10–15%). According to the tumor extension, SCTs are
classified into four categories by the American Pediatric
Surgery Association: type I, lesions almost completely
external; type II, predominantly external masses with pelvic
extension; type III, external tumors with intra-abdominal
extension; type IV, exclusively intra-abdominal lesions
[17]. Fetal tumors are usually large exophytic masses
(Fig. 1a, b) with a high incidence of complications, such
as polyhydramnios, fetal cardiac failure, fetal hydrops,
tumoral hemorrhage and prematurity [11], which are related
to the tumor size and to the effect of the intrapelvic and
intra-abdominal tumor components over the developing
organs [18]. The differential diagnosis includes lipoma,
dermoid and lumbosacral myelomeningocele [19].
Cervicofacial teratomas (Fig. 1c, d) have an incidence of
1:40,000 to 1:80,000 live births. They may originate in
different anatomical structures, including the orbit, the
naso- and oropharynx, the tongue, the palate and the anterior
neck [19]. Cervical teratomas in utero may not only cause
hydrops secondary to fetal swallowing disturbances, but also
fetal pulmonary hypoplasia. Large tumors may cause
hyperextension of the fetal neck with resulting dystocia
[20]. Ex utero intrapartum treatment, or EXIT, has been
performed in recent years in cases of giant neck masses in
highly specialized neonatal medical centers, improving the
initial fetal survival [21, 22].
Thoracic teratomas originate mainly in the pericardium
[11]. Pericardial effusion is typically present and may lead
to life-threatening tamponade. Indeed, in cases of fetal
pericardial effusion, teratoma should be seriously consid-
ered in the differential diagnosis. Pericardiocentesis can
help to prevent fetal death. Mediastinal teratomas are rare.
They should be removed after birth to prevent malignant
degeneration [23].
Congenital sacrococcygeal and cervicofacial teratomas
present an overall mortality of 30–33.5%, mainly related to
large tumors with extensive local infiltration [11]. The main
role of pre- and postnatal imaging for teratomas is to
recognize any associated anomalies and to determine the
full extent of the mass for prognosis and evaluation of
surgical planning. On fetal ultrasound, teratomas are seen as
large, heterogeneous masses due to their different tissue
components. In some cases of SCT, an accurate ultrasound
evaluation may be insufficient because of shadowing by the
fetal pelvic bones, which may cause an underestimation of
the tumor [18]. Fetal MRI is therefore considered the
method of choice for evaluating the extent of the internal
mass (Fig. 1a). Indeed, the method can serve as a roadmap
before surgery, as ultrasound images are sometimes difficult
to interpret for clinicians and may fail to provide a good
overview of the limits of the relation between the tumor and
the surrounding anatomy. Post-natal CT and MRI studies
show a heterogeneous mass with solid, liquid and fat
components (Fig. 1d), and variable contrast enhancement.
Calcifications and bone tissue are often found and are better
recognized on CT (Figs. 1, 2b).
Neuroblastoma
The neuroblastoma is the second most common pediat-
ric malignancy overall, after teratoma, in most pub-
lished series [3, 5] and the most common malignancy of
the first month of life (30–50%] [8]. The tumor arises
from primordial neural crest cells, anywhere along the
sympathetic chains, at the adrenal medulla (Fig. 2b), the
extra-adrenal retroperitoneum (Fig. 2c, d) or the posterior
mediastinum.
Fetal neuroblastoma is usually detected during the third
trimester of pregnancy. It is mostly of adrenal origin (90%
of cases). The prognosis is excellent, with a survival rate of
Table 1 Distribution of main congenital tumors [2, 3, 5–8]
Type of tumor %
Extracranial teratomas 23.5–29%
Neuroblastomas 22.5–30%
Soft tissue tumors 8.1–12%
CNS tumors 5.9–10%
Leukemia 5.9%–12.35%
Renal tumors 5–7.1%
Hepatic tumors 5%
Cardiopulmonary tumors <3%
298 Insights Imaging (2011) 2:297–30888–90% [1, 24], metastases are rare and spontaneous
involution in utero has been described. On ultrasound, the
tumor is mostly seen as a solid, heterogeneous echogenic
mass that displaces the adjacent kidney inferiorly and
laterally. Cystic tumors are often seen and have an excellent
prognosis [24]. Calcifications are present in 30% of all
cases. On MRI, neuroblastomas are typically heteroge-
neous, with relatively low signal intensity on T1- and high
signal intensity on T2-weighted images. Cystic changes
appear as bright areas on T2-weighted images [8].
Neonatal neuroblastomas are of adrenal origin in 45%
(Fig. 2b) and of extra-adrenal origin in 55% of all cases
(Fig. 2c, d]. Although often metastatic [60% of cases,
principally liver (Fig. 2c), bone and skin], it has an overall
survival rate of 64% [1, 24]. On CT, the tumor is
heterogeneous, with calcifications, necrosis and areas of
hemorrhage. Extension into the spinal canal is seen in
10% of abdominal (Fig. 2d) and in 28% of thoracic
masses, and is clearly visualized on MRI studies [8].
Metaiodobenzylguanidine (MIBG-I
123) scintigraphy is an
excellent method for determining the presence of metas-
tases or tumor recidivation, but 30% of neonatal tumors
are MIBG-negative [25].
The International Neuroblastoma Staging System [26]i s
mainly based on the degree of surgical resection and shows
some difficulties for application in congenital cases. Recently,
a new International Neuroblastoma Risk Group Staging
System (INRGSS), based on imaging findings, was designed
to stage the patients at the time of diagnosis. In this
classification, the extent of locoregional disease is determined
by the absence (L1) or presence (L2) of imaging-defined risk
factors [27], with stage M used for widely disseminated
disease and stage MS for metastatic disease limited to liver,
skin and bone narrow in children younger than 18 months
[28]. The main role of imaging methods for both fetal and
neonatal neuroblastoma is then to determine the origin of the
mass, its locoregional extent and the presence or not of
metastases for staging before therapy.
Fig. 1 Extracranial teratomas.
Case 1. SCT. Coronal (a) and
sagittal T2-TRUFI (b) fetal
MRIs (29th week) show the
large, complex SCT type II with
both cystic (arrow) and solid
components. The images clearly
illustrate the extension of the
tumor into the pelvis, the abdo-
men and the spinal canal (block
arrow). Case 2. Cervical
teratoma (3 months old). The
CT topogram (c) and the axial
NECT image (d) demonstrate
the heterogenicity of the tumor,
with calcifications (white
arrows), fat, solid and liquid
(star) components
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Congenital soft-tissue tumors constitute a heterogeneous
group of lesions, including mainly vascular and muscular
tumors. The International Society for the Study of Vascular
Anomalies (ISSVA) differentiates between vascular tumors
and vascular malformations (capillary, venous, lymphatic or
mixed) [29], which are not discussed in this review.
Infantile hemangiomas (IH) are true neoplasms that
originate from the cellular proliferation of vascular endo-
thelial cells. They account for a significant number of
prenatally diagnosed neoplasms [30], but because most of
them are small or absent at birth, they are often not
included in the register of congenital tumors [1]. The most
frequent location is the head and neck (60%) (Fig. 3b). IH
usually present a biphasic cycle, with initial rapid growth
followed by an involution over months or years. Most IH
require neither therapy nor imaging studies. On ultrasound,
they appear as lobulated, hypo- or hyperechoic, well-
defined masses with increased Doppler flow.
The notion of congenital hemangiomas has been
introduced recently, differentiating between non-involuting
congenital hemangiomas, or NICH, and rapidly involuting
congenital hemangiomas, or RICH [31]. Although both
RICH and NICH groups show similar imaging findings to
IH on ultrasound, they may also present vascular aneu-
rysms, intravascular thrombi and arteriovenous shunting,
features not usually observed in IH [32]. Large congenital
tumors may cause compression of vital structures or
cardiovascular complications, and in these cases, MRI is
the method of choice to determine the mass extension and
its relationship to the adjacent anatomical structures
Fig. 2 Neuroblastoma. Case 1.
Typical neuroblastoma. The ab-
dominal ultrasound (a) and the
axial fat-saturated T2-weighted
images (b) show the well-
defined, homogeneous mass
arising from the right adrenal
gland (white arrow) and dis-
placing the kidney in this
2-day-old baby. Case 2. Axial
contrast-enhanced CT (CECT)
(c) shows the enhancing retro-
peritoneal tumor (white arrow)
originating from the organ of
Zückerkandl in this 10-day-old
girl. Note the hepatic infiltration
(arrow). Case 3. Axial CECT
(d) shows the mass arising from
the right paraspinal sympathetic
chain and extending into the
spinal canal in this 3-day-old
baby boy. Note the enlargement
of the spinal canal (white block
arrow). Case 4. Atypical neuro-
blastoma. Axial ultrasound (e)
and T1-weighted images after
i.v. contrast medium administra-
tion (f) show the retroperitoneal,
lobulated mass infiltrating the
right kidney and causing hydro-
nephrosis (arrow) in this
5-week-old baby. The lesion
was initially considered to be a
renal tumor, but histology
revealed neuroblastoma
300 Insights Imaging (2011) 2:297–308(Fig. 3c, d). Hemangiomas are usually hyperintense on
T2-weighted and isointense on T1-weighted images related
to muscle, with prominent draining veins [5] and intense
enhancement after contrast medium administration [33], but
no perilesional edema.
Fibrous connective tissue tumors are the largest group of
congenital soft-tissue tumors. Fibromatosis and myofibroma-
tosis are rare benign disorders with a tendency to infiltrate
adjacent tissues but no metastases. They present an increment
of the size and the number of lesions during the first year of
life with later regression. The ultrasound shows a soft-tissue
mass with variable echogenicity. They are muscle isodense
and poorly defined on CT (Fig. 3d), with low signal intensity
on both T1-weighted and T2-weighted images [34], infiltra-
tion of the fat and muscle, and intense enhancement after i.v.
contrast medium injection on MRI. The malignant variant is
the congenital infantile fibrosarcoma [1].
Rhabdomyosarcoma arises from the embryonic mesen-
chyme with the potential to differentiate into skeletal muscle.
The tumor represents >50% of all soft tissue sarcomas in
children, but its congenital presentation isextremely rare [35].
It can arise in any anatomical region of the body (except
bone) whether there is skeletal muscle or not, but most often
it presents in the head and neck (28–40%) and in the
genitourinary region (20%). The ultrasound shows a soft-
tissue mass, similar to muscle, whereas MRI reveals a mass
isointense to muscle on T1-weighted and hyperintense on
T2-weighted images, with heterogeneous enhancement after
gadolinium administration. Some previously classified con-
genital rhabdomyosarcomas with a bad outcome were
probably unrecognized rhabdoid tumors. Immunochemistry
tests show that rhabdoid tumors typically lack staining for
BAF47 in tumor cells because of a clonal mutation in the
INI1 gene [36]. This anomaly now allows correct differen-
tiation between rhabdoid tumors—usually associated with a
bad prognosis—and rhabdomyosarcomas [37].
The main role of imaging in the case of congenital soft
tissue tumors is to determine the extent of the mass and to
identify the invasion of adjacent structures in order to
optimize the surgical approach.
Central nervous system tumors
Congenital tumors of the central nervous system (CNS) are
rare. They have a poor prognosis with an overall mortality
of 72% [37–41]. They represent only 0.5–1.9% of all
pediatric brain tumors, but are responsible for 5–20% of
deaths secondary to neoplasms in this age group [6, 38].
Congenital CNS tumors differ in histology, location,
biological behavior and response to therapy compared with
CNS tumors in older children. The most frequent tumor
Fig. 3 Soft-tissue tumors. Cases 1 and 2. Congenital hemangiomas.
Coronal (a)a n da x i a l( b) fetal T2-HASTE MRI (21st week)
demonstrate the cephalic, but completely extracranial heterogeneous
mass (star). The axial (c) and coronal (d) T2-weighted images show
the homogeneous hyperintense mass in the left posterior mediastinum,
extending into the spinal canal (arrow) in this newborn. The mass was
biopsied to exclude a neuroblastoma. Case 3. Cervical myofibroma-
tosis in a 2-month-old boy. Axial CECT image (e) shows the large,
infiltrating left cervical muscular mass, with intense enhancement after
contrast medium administration
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congenital tumors (about 60%) are supratentorial, arising
from the pineal gland, the suprasellar area or the cerebral
hemispheres. Macrocephaly is usually the first clinical
finding. Increased intracranial pressure signs are not often
observed because of the great capacity for accommodation
to the increased volume in the fetus and in neonates with
opened sutures [35]. Intratumoral hemorrhage is relatively
common, varying between 3 and 18% [38–40].
Teratoma is the most common congenital brain tumor
and represents 26.6 to 48% [38–41] (Table 2). Congenital
teratomas are predominantly supratentorial, with the cere-
bral hemispheres being the main primary site, followed by
the third ventricle and the pineal region [42]. On ultra-
sound, they are seen as typically large, mid-line heteroge-
neous tumors with solid areas replacing much of the brain.
Cystic components are often found [41] and probably
represent necrotic areas in tumors with a rapid growth rate.
Calcifications are possible, but unusual.
The astrocytoma is the most common neuroglial tumor.
The cerebral hemispheres are the main primary site,
followed by the optic nerve, the thalamus and the
mesencephalus. They typically present with macrocephaly.
Fetal ultrasound and MRI show a solid tumor replacing the
normal brain parenchyma. Hemorrhage is common.
The choroid plexus papilloma is composed of mature
epithelial cells derived from choroid plexus epithelium. It
presents clinically as macrocephaly, with rapid onset of
hydrocephalus, secondary to the overproduction and/or
mechanical obstruction to cerebrospinal fluid (CSF) circu-
lation [1]. These are well defined, intraventricular masses,
hyperechoic on ultrasound and mostly hyperattenuating on
CT (Fig. 4a, b), with intense contrast enhancement. On
MRI, they present as homogeneous masses on T1-weighted
images, with the central tumor areas hypointense compared
with grey matter on T2-weighted images [43]. Complete
surgical resection is curative, but intraoperative hemorrhage
is common and may have serious consequences. Choroid
plexus carcinomas are very rare in neonates. They are often
associated with marked vasogenic edema and may be
hyperdense on CT because of the high cellularity.
Primitive neuroectodermal tumors (PNET) (Fig. 4c, d)
are small-cell malignant tumors arising from the neural
crest [40]. The most common locations are the cerebellum
and the cerebral hemispheres. Congenital tumors have a
poor prognosis as a consequence of the rapid tumor growth,
with early extension throughout the CSF pathways.
The diagnosis of fetal and neonatal brain tumors is
associated with high mortality rates (Table 2). Recent
advances in MRI technology include the development of
magnetic resonance diffusion sequences (DWI), which may
identify areas of restricted water movement and of magnetic
resonance spectroscopy (MRS), which recognizes changes in
metabolite concentration [44]. These technical improvements
have opened up exciting perspectives, suggesting the
possibility of differentiating between histological tumor
types [20, 45], but preliminary reports have not yet been
confirmed for congenital brain tumors. The main role of
imaging studies is still to determine the extent of the tumor
in order to evaluate therapy challenges and to identify
potentially curable tumors, such as plexus papillomas,
differentiating them from rapidly fatal ones.
Renal tumors
Renal tumors represent 5–7.1% of all congenital tumors
(Table 1). They are mostly benign, with the most frequent
histological types being mesoblastic nephroma (MSN),
nephroblastomatosis and the multilocular cystic nephroma
[14]. Wilms’ tumor and renal rhabdoid tumors are rare in
neonates [1, 14, 46].
The MSN represents 66% of all congenital renal tumors
[14]. It is a benign hamartomatous tumor, arising from
proliferating nephrogenic mesenchyme. Fetal tumors have a
worse prognosis than neonatal ones [14]. They present in
utero as large, solid, infiltrative, unilateral renal masses
[47], sometimes associated with polyhydramnios. Hyper-
calcemia has been described in neonatal cases [1, 3]. The
tumor has variable echogenicity, with homogeneous solid
tissue on ultrasound. CT and MRI show a solid, relatively
homogeneous renal tumor, typically involving the renal
sinus and with variable contrast enhancement (Fig. 5a, b).
The mass may present cystic and hemorrhagic areas [46].
Nephroblastomatosis consists of diffuse, multifocal
nephrogenic rests in the kidneys. It is found incidentally
in 1% of normal children at post-mortem studies and may
cause a Wilms’ tumor in 30–40% of the cases (Fig. 5c).
Thereisawell-knownassociationwithBeckwith-Wiedemann
syndrome, trisomy 18 and sporadic aniridia [48]. Typical
ultrasound images show multifocal, subcapsular renal nod-
ules, hypo- or isoechoic, related to renal parenchyma. The
nodules present low attenuation on CT and low signal
intensity on both T1- and T2-weighted images on MRI
Table 2 CNS tumors. Histological type and mortality rate of main
CNS tumors [37–41]
CNS tumors % Mortality rate
Intracranial teratomas 26.6–48% 88%
Astrocytomas 7.4–28.8% 64–68%
Choroid plexus papilloma 3.7–13.2% 27%
PNET 3–13% 88%
Craniopharyngioma 5.6–6.8% 76.5%
Ependymoma 4.4% 91%
302 Insights Imaging (2011) 2:297–308relative to normal parenchyma, with reduced contrast
enhancement.
Multilocular cystic nephroma (MCN) is a benign cystic
renal neoplasm, arising from metanephric blastema. Imag-
ing shows a large multilocular cystic renal mass, with septa
as the only solid component (Fig. 5d). Septa may enhance
after contrast medium administration. Metastatic disease
has not been reported.
The role of imaging studies for congenital renal tumors
is to determine the extent of the mass and its relationship to
the renal vascular structures before surgical therapy.
Hepatic tumors
Hepatic tumors comprise 5% of all congenital neoplasms
(Table 1). Excluding metastases, principally from leukemia
and neuroblastoma [1], most primary hepatic tumors are
hemangiomas (60.3%), followed by mesenchymal hamar-
toma (23.2%) and hepatoblastoma (16.5%) [13].
Theinfantilehepatichemangioma,frequentlyreferredtoas
hepatic hemangioendothelioma, is the most common congen-
ital vascular hepatic tumor [13, 49]. It is a benign lesion
composed of large endothelial-lined vascular channels. The
clinical and biological behavior show initial proliferation and
subsequent involution [50]. Hepatic hemangiomas may be
focal (solitary) or multifocal, confluent lesions (Fig. 6a).
Although spontaneous involution is possible, rapid growth
may instigate fetal anasarca (Fig. 6b), thrombocytopenia
resulting from consumptive coagulopathies (Kasabach-
Merritt syndrome) or postnatal death due to cardiac
failure [23]. On ultrasound, focal hemangioma is classi-
cally a well-defined, hypo-, iso- or hyperechogenic lesion
with a prominent high flow on Doppler ultrasound [47].
Calcifications are common. Large tumors present as well-
defined, solid masses, often with central necrosis. Most
lesions are hypodense compared with the rest of the liver
on non-enhanced CT [49]. After contrast medium admin-
istration, they show a centripetal enhancement that
acquires uniformity on delayed CT. On MRI, the lesions
Fig. 4 Intracranial tumors. Case
1. Choroid plexus papilloma.
Axial T2-weighted fetal MRI
(34th week) (a) shows an intra-
ventricular, solid mass in the
posterior horn of the right lateral
ventricle (white arrow). Postna-
tal axial T2-weighted image (b)
3 days after birth reveals an
increase in the tumor size. Note
the extensive paraventricular
edema. Case 2. PNET. Sagittal
T1-weighted image after i.v
contrast medium administration
(c) and coronal T2-weighted
image (d) in this 6-week-old
boy presenting with macroce-
phaly show the heterogeneous
tumor in the posterior fossa
(arrow), with both solid and
liquid (block arrow) compo-
nents. The tumor causes a sec-
ondary hydrocephalus
Insights Imaging (2011) 2:297–308 303usually show low T1 and high T2 signal intensities, but
may be heterogeneous because of hemorrhage and
calcification [49], with variable enhancement patterns.
Necrotic or thrombotic regions show a heterogeneous
signal both before and after gadolinium administration.
The mesenchymal hamartoma is a developmental cystic
tumor, resulting from the benign overgrowth of mature
hepatic tissue, with variable loose mesenchyme. Associa-
tion with Beckwith-Wiedemann syndrome has been
reported. Ultrasound shows a tumor composed of variably
sized anechoic cysts with internal septations. Solid tumors
have been described, but they are atypical [47, 51]. On MRI
the cysts are fluid isointense lesions with septa and stromal
components (Fig. 6c)[ 52].
Congenital hepatoblastoma is a malignant embryonic
tumor composed of only epithelial cells or a mixture of
epithelial and mesenchymal cells. They present as lobulat-
ed, sometimes multifocal large solid masses, most often in
the right hepatic lobe (60%). An association with hemi-
hypertrophy (2%), Beckwith-Wiedemann and intestinal
polyposis is well established. The α-fetoprotein may be
negative in a considerable percentage of fetal and neonatal
tumors [13]. Ultrasound shows a well-defined, solid mass
(Fig. 6d), often with a spoked-wheel appearance. The lesion
is heterogeneous, with calcifications (50%), cystic and
necrotic areas [47]. CT and MRI show a heterogeneous
solid hepatic lesion with non-uniform enhancement.
The differential diagnosis of congenital hepatoblastoma
is the malignant hepatic rhabdoid tumor. The most
extensive published series about congenital hepatic tumors
describes a poor prognosis for hepatoblastomas, with
common early metastases and high mortality rates [13],
but this series probably includes some cases of congenital
rhabdoid tumors, an aggressive lesion previously classified
as hepatoblastoma with negative α-fetoprotein. As men-
tioned elsewhere in this article, immunochemistry tests for
INI1/BAF47 protein, which is abnormally low in all
rhabdoid tumors, have recently allowed a correct differen-
tiation between the entities [36, 37, 53, 54], which present
similar findings on imaging studies.
The main role of imaging methods for congenital hepatic
tumors is to evaluate the anatomical extent of the tumor and
to clarify the relationship with hepatic lobar anatomy before
surgical planning.
Cardiopulmonary tumors
The heart is one of the most common organs of origin of
congenital tumors, with a reported incidence of 0.14 to
0.2% [55]. The incidence has been increasing in recent
years because of the technical advances of imaging studies,
especially ultrasound cardiography and cardiac MRI.
Cardiac tumors may be related to genetic disorders such
Fig. 5 Renal tumors. Case 1.
Mesoblastic nephroma. Axial
CECT (a) and fat-saturated
T1-weighted image after i.v.
contrast medium administration
(b) show a solid, focal renal
mass replacing the normal right
renal parenchyma (block
arrows) in this newborn boy.
Case 2. Nephroblastomatosis
with bilateral Wilms’ tumors.
Axial CECT (c) shows the well-
defined bilateral renal masses
(stars) in this 3-month-old baby,
corresponding to a histologically
proven bilateral Wilms’ tumor in
a child with areas of nephro-
blastomatosis. The masses re-
main hypodense compared with
normal renal parenchyma.
Wilms’ tumors are very rare in
fetuses and neonates. Case 3.
MCN. T2-HASTE MR image
(d) shows a multilocular cystic
mass in the right kidney with
tumor septae. Observe a similar
but smaller left renallesion(white
arrow) in this 10-week-old boy
with multiple congenital tumors
(same patient as in Fig. 6c)
304 Insights Imaging (2011) 2:297–308as neurofibromatosis, Beckwith-Wiedemann syndrome,
familial myxoma syndrome and tuberous sclerosis. Most
fetal and newborn cardiac tumors are benign. The most
frequent cardiac tumor is the myocardial rhabdomyoma
(78%), followed by the pericardial teratoma (18%) and the
cardiac fibroma (12%) [12]. Pericardial teratoma has
already been described in this article.
The rhabdomyoma is a hamartoma, and as such it is not
considered a true neoplasm. Its incidence oscillates between
0.12% in prenatal fetal studies and 0.02–0.08% in live-born
infants [55, 56]. The tumor is multiple in >90% of cases,
not invasive and not metastasizing [12]. Rhabdomyoma
shows a high association with tuberous sclerosis (86%) and
may manifest as the earliest clinical sign of this patholog-
ical condition in utero. Indeed, the detection of multiple
cardiac rhabdomyomas on prenatal ultrasound is considered
sufficient to establish the diagnosis of tuberous sclerosis
[57] and makes MRI evaluation of the fetal CNS mandatory
[58]. Clinical findings oscillate from asymptomatic to
congestive heart failure, arrhythmias, valvular dysfunction
and sudden death, which cause a mortality of 40%. Surgical
intervention is only recommended in cases of persistent
arrhythmias or severe hemodynamic compromise because
rhabdomyomas usually increase in size until late pregnancy
and then tend to regress progressively during the first year
of life. Rhabdomyomas have been detected as early as the
19th week of pregnancy. They appear as rounded and
homogeneous hyperechogenic areas (Fig. 7a), originating
from the ventricular septum or the ventricular wall. Cardio-
ultrasound is the imaging method of choice and provides a
dynamic evaluation of the myocardial wall motion and the
valvular functionality.
Pleuropulmonary congenital neoplasias are extremely
rare. The pleuropulmonary blastoma is a primary mesen-
chymal neoplasm with a very poor prognosis. On prenatal
ultrasound and MRI, it presents as a solid heterogeneous
mass originating from the pleura or the pulmonary
parenchyma (Fig. 7b), often with additional pleural effusion
(Fig. 7c). After birth, the tumor may manifest as a benign-
appearing, air-filled cystic lesion or as large heterogeneous
Fig. 6 Hepatic tumors. Case 1.
Multiple hepatic hemangiomas.
Coronal T2-HASTE MRI (a)
shows the multiple hyperintense
hepatic lesions (white arrows).
Observe the right hemihypertro-
phy in this newborn with
Beckwith-Wiedemann syndrome
(vertical arrows). Case 2.
Hemangioendothelioma.
Coronal (b) T2-HASTE MRI
(27th week) shows a large and
infiltrating mass arising from the
left hepatic lobe with predomi-
nantly high signal intensity. Ob-
serve the signs of fetal
congestive heart failure with
marked hydrops fetalis (white
block arrows). Case 3. Mesen-
chymal hamartoma. Axial
T2-weighted image (c) shows a
centrally located, hepatic hyper-
intense cystic mass with internal
septations in this 10-week-old
boy(samepatientasinFig.5d, e).
Case 4. Hepatoblastoma.
Abdominal ultrasound (d)s h o w s
the large, heterogeneous mass in
the right hepatic lobe of this
2-day-old girl
Insights Imaging (2011) 2:297–308 305solid masses. The main differential diagnoses include the
rhabdomyosarcoma and the undifferentiated sarcoma.
Conclusion
Congenital tumors are a unique, heterogeneous group of
neoplasms that differ in many aspects from tumors
presenting later in life. Congenital fetal and neonatal
neuroblastomas are associated with a better prognosis
than tumors detected later in life, but they remain an
exception. Although mostly benign, the therapeutic
possibilities of most congenital tumors may be limited
because of the tumor size, its location or the stage of the
pregnancy at the time of diagnosis. Moreover, the low
incidence and the great histological diversity of these
tumors reduces the number of published articles about
them. Indeed, most of the published reference series are
retrospective studies, including cases diagnosed and treated
forthelast20–30yearsandgivingmortalityvaluesthatarefar
away from actual reality in pediatric hospitals [2, 3, 10–14].
Although prediction of the possible prognosis and postnatal
outcome is complicated, perinatal, anesthetic and surgical
care is constantly improving nowadays such that more
infants survive in general.
In recent years, imaging methods have acquired a
relevant role in the diagnosis of fetal tumors. Ultrasound
is the standard method for fetal evaluation: it is ideal for
screening, safe for mother and child, widely accessible and
relatively inexpensive, but its effectiveness may be limited
by factors such as oligoamnios, maternal body habitus, fetal
position and fetal shadow bone artifacts. Prenatal MRI is
increasingly being used as a complementary imaging
technique, but its real utility for congenital tumors has not
yet been widely evaluated. In general, fetal MRI should
only be performed if it is considered that additional results
might influence the management of the pregnancy and/or
the therapeutic approach. Recent articles have shown a
more accurate evaluation of MRI compared with ultrasound
in some cases of congenital tumors, including the local
anatomical extent of sacrococcygeal and cervicofacial
teratomas, which may be underestimated on ultrasound
because of fetal bone shadowing [18, 23]. MRI may also
discriminate between cystic and hemorrhagic areas with T1
or T2* sequences, information that may be relevant for
evaluating the therapeutic challenges for SCT [18, 23] and
Fig. 7 Cardiopulmonary tumors. Case 1. Rhabdomyoma. The cardio-
ultrasound image (a) shows the multiple hyperechoic tumors
originating from the ventricular septum (arrows) and the ventricular
walls. Observe the large mass in the right ventricle (star) of this
asymptomatic 3-day-old newborn boy with tuberous sclerosis. Case 2.
Pleuropulmonary blastoma. Axial fetal ultrasound (b, 22nd week) and
fetal T2-WI (c, 24th week) demonstrate a well-defined, hypoecho-
genic, solid mass, isointense to lung on MRI (block arrow). Observe
the pleural effusion (curved arrow)
306 Insights Imaging (2011) 2:297–308some intracranial tumors. MRI also seems to be better in
the evaluation of the deep extension of large tumors that do
not always respect anatomical planes, such as hemangiomas
or cervicofacial teratomas [20, 32]. Moreover, MRI allows
a complete examination of the spinal canal in paraverte-
brally located tumors, such as neuroblastomas or SCT [23].
Finally, MRI performed during late pregnancy provides
excellent anatomical details in a safe intrauterine environ-
ment, which may delay the need for immediate postnatal
imaging.
Brain tumors are a special group of congenital neo-
plasms. The detection of a congenital brain tumor in a fetus
is followed by serious ethical considerations about the real
prognosis, postnatal quality of life, therapy challenges and
long-term consequences of the applied therapy. The low
incidence, great diversity and different behaviors of
congenital brain tumors compared with tumors in older
patients mean that published results, obtained from older
children and adults, cannot be directly extrapolated. Overall
prognosis is poor and therapeutic options limited, with an
evident discrepancy between our diagnostic capacities and
our therapy possibilities. A confident identification of the
individual tumor types based on imaging is almost
impossible, and therefore, in countries in which a legal
medical interruption of pregnancy is possible, this diagnosis
may lead to a high rate of legal abortions [44].
In conclusion, ultrasound and MRI have increased the
rate of detection of congenital tumors in prenatal life.
During pregnancy and after birth, the main role of imaging
is to provide accurate information about the origin and the
extent of the tumor, the invasion of adjacent organs, and the
presence or absence of metastasis. This information is
crucial for reducing the differential diagnosis and to
evaluate and optimize the pre- and postnatal therapeutic
challenges. A correct knowledge of the possibilities of the
different imaging techniques in fetal and neonatal studies
would improve all obtainable information, helping the
medical team to make the most appropriate decisions about
therapy. Prenatal ultrasound remains the standard diagnostic
method, but fetal MRI seems to be an excellent comple-
mentary imaging technique, and its real utility should be
evaluated in larger, multicentric series.
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